With more than 40 companies on its roster, Johnson & Johnson Innovation’s life sciences incubator JLABS @ Toronto is celebrating a successful first year. One of eight such facilities around North America, JLABS provides early stage startups with space and expertise to get their ideas off the drawing board.
One of those companies is WinterLight Labs, which joined JLABS in January. WinterLight is developing an artificial intelligence platform that analyzes speech patterns to possibly diagnose neurological conditions, such as Alzheimer’s or Parkinson’s disease.
Like a blood test looking for biological markers, WinterLight’s technology seeks to isolate cadence, word choice and other voice markers that might indicate a neurological issue.